AdvaMed® Statement on Media Reports of Price Gouging
WASHINGTON, D.C. – President and CEO of AdvaMed® Scott Whitaker released the following statement: “Given recent allegations of price gouging in some parts of the country, it is important to be…
Tens of Thousands of Life-saving Ventilators on Deck to Combat COVID-19
WASHINGTON, D.C. – The Advanced Medical Technology Association® announced today that its member respiratory device companies have dramatically expanded the limits of their present production capacity in responding to the…
COVID-19 Test Availability Rapidly Scales Up
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today released the following statements by Scott Whitaker, AdvaMed® president and CEO, and Susan Van Meter, executive director of AdvaMedDx®, regarding the medtech…
AdvaMed® Applauds Congressional Passage of CARES Act
WASHINGTON, D.C. – Today, AdvaMed® President and CEO Scott Whitaker released a statement applauding congressional passage of the Coronavirus Aid, Relief, and Economic Security (CARES) Act.
Industry Welcomes Government Direction On Allocation of Ventilators
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today sent a letter to the Federal Emergency Management Agency (FEMA) and the administration calling for centralization of procurement and allocation decision-making for medical ventilators…
Diagnostics Manufacturers Ramping Up COVID-19 Tests to Combat Pandemic
WASHINGTON, D.C. – Several diagnostics companies have received or will soon receive FDA Emergency Use Authorizations (EUA) that will provide crucial capacity for the U.S. to significantly ramp up testing for the coronavirus (COVID-19). …
Diagnostics Manufacturers Ramping Up COVID-19 Tests to Combat Pandemic
WASHINGTON, D.C. – Several diagnostics companies have received or will soon receive FDA Emergency Use Authorizations (EUA) that will provide crucial capacity for the U.S. to significantly ramp up testing for the coronavirus (COVID-19).
FDA Commissioner Hahn Addresses AdvaMed® Board of Directors on Coronavirus
WASHINGTON, D.C. – FDA Commissioner Dr. Stephen Hahn joined a special meeting of AdvaMed®’s Board of Directors today to discuss how the medical technology industry and FDA can continue their work…
VALID Act Introduction Advances Diagnostics Regulatory Reform
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon introduction today in the House and Senate of the Verifying Accurate,…
VALID Act Introduction Advances Diagnostics Regulatory Reform
WASHINGTON, D.C. – AdvaMed® President and CEO Scott Whitaker and AdvaMedDx® Executive Director Susan Van Meter issued the following statements upon introduction today in the House and Senate of the Verifying Accurate,…